Individuals with Down syndrome (DS) constitute a population at ultrahigh risk of developing Alzheimer disease (AD) because of trisomy of chromosome 21, which harbors the APP (amyloid precursor protein; OMIM 104760) gene. This evidence concerns the gene APP and Dravet syndrome.